Roche receives FDA approval for companion diagnostic tests to identify patients with HER2-positive metastatic gastroesophageal adenocarcinoma eligible for ZIIHERA

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received FDA approval for expanded use of its PATHWAY® HER2 ...

FDA Approves Breakthrough Pancreatic Cancer Pill That Nearly Doubles Survival Time In Studies

In a randomized, open-label, multicenter trial of 500 adults with previously treated metastatic pancreatic adenocarcinoma, ...
The Western Journal on MSN

FDA approves 'landmark' cancer drug that extended patients' lives in trial

The Food and Drug Administration announced Wednesday the approval of a new pancreatic cancer treatment drug that nearly ...

New drug targets offer potential pathway for pancreatic cancer treatment

Peter Mac researchers have identified potential new drug targets for pancreatic cancer by uncovering proteins cancer cells ...

‘Critical new option’: FDA approves pill to treat advanced pancreatic cancer

The FDA on Wednesday said it approved the drug, Rasonque, known generically as daraxonrasib, for adults with metastatic ...
Healio

Rasonque nabs FDA approval for previously treated metastatic pancreatic adenocarcinoma

The FDA has approved a first-in-class targeted therapy for adults with metastatic pancreatic adenocarcinoma.Daraxonrasib ...
Medscape

Biomarkers Offer Clues to Prognoses in Lung Adenocarcinoma

BOSTON — Key DNA and chromosomal and immune cell changes in early-stage lung adenocarcinoma show significant associations with outcomes, representing potentially important early predictors to guide ...
Medical Xpress

2000 to 2021 saw increase in incidence of pancreatic adenocarcinoma

From 2000 to 2021, there was an increase in the incidence of pancreatic adenocarcinoma, which was seen in all age groups, according to a study published online April 14 in JAMA Network Open. Arvind ...